Optimus Health Care
Molnupiravir (200mg)
Molcovir 200mg Tablet is the first oral antiviral medication that helps treat mild to moderate COVID-19 in adults.
Tablet
Molcovir 200mg Tablet is only indicated in patients with mild to moderate COVID-19 symptoms and who have a high risk of developing severe symptoms. The risk factors include obesity, older age (>60 years), diabetes mellitus, and heart diseases. It is not indicated in patients who require immediate hospitalization due to COVID-19. This drug has also been approved by the U.S. Food and Drug Administration (FDA) and the UK regulatory agency for emergency use. Molcovir 200mg Tablet should be taken orally for no longer than 5 consecutive days. It is important to complete the entire 5 days of treatment, therefore do not stop taking it even if you feel better. The medicine may cause dizziness, headache, diarrhea, and nausea in some patients. If one experiences any such side effects, discuss them with the doctor. They may help with the treatment or suggest ways to prevent them. Before taking Molcovir 200mg Tablet, let the doctor know if you have any pre-existing medical conditions. To make sure it is safe for you, inform your doctor about all the other medications you are taking. The use of Molcovir 200mg Tablet is not recommended in pregnant women. Pregnant and breastfeeding women should consult with their doctors before taking this medicine.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Molcovir 200mg Tablet may be taken with or without food, but it is better to take it at a fixed time.
No common side effects listed.
It is not known whether it is safe to consume alcohol with Molcovir 200mg Tablet. Please consult your doctor.
Molcovir 200mg Tablet is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Molcovir 200mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Abacavir Adefovir Didanosine Entecavir
Molcovir 200mg Tablet is an antiviral medicine. It works by inhibiting the SARS-CoV-2 virus from replicating. This stops the virus from producing new copies and hence decreases the viral load in the body.
Do not give Molcovir 200mg Tablet to children and adolescents aged less than 18 years. Do not stop taking Molcovir 200mg Tablet without talking to your doctor first as it will protect you from becoming severely ill from COVID-19. Even after the treatment, continue practicing COVID-appropriate behavior such as wearing a mask, social distancing, and frequent handwashing. For individuals with conceiving potential, it is advisable to use contraceptive methods while taking Molnupiravir and for 4 days after the last dose of the medicine.
No, Molcovir 200mg Tablet is not approved for use in children or patients below the age of 18 years as it may interfere with bone and cartilage growth.
Molcovir 200mg Tablet offers better patient compliance compared to some other treatment options for COVID-19. Unlike medications requiring skilled healthcare professionals (doctors or nurses) for administration, Molcovir 200mg Tablet is an oral medication that can be consumed as prescribed by the doctor.
Yes. There are potential serious risks associated with using Molcovir 200mg Tablet, including its potential to cause birth defects in pregnant women and serious damage to bone and cartilage growth (which may lead to severe muscle damage). Therefore, Molcovir 200mg Tablet should only be used if prescribed by a doctor and not self-medicated.
No. There is no comparison between the two, and Molcovir 200mg Tablet is not a substitute for vaccination. Vaccination is intended for prevention, while Molcovir 200mg Tablet is used to treat an existing COVID-19 infection only if diagnosed at an early stage.
Individuals with an increased risk of developing severe COVID-19 include those aged 60 years or older, those who are obese, and patients with comorbid conditions such as high blood pressure, diabetes, asthma, lung diseases, kidney disease (including dialysis patients), liver problems, or compromised immunity (for example, cancer patients).
Molcovir 200mg Tablet is not intended for preventing COVID-19 or treating hospitalized patients with COVID-19. According to ongoing clinical trials, those hospitalized with severe COVID-19 infection have not shown benefit from taking Molcovir 200mg Tablet.